These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 19008150)

  • 61. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 62. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
    De Rochars MB; Direny AN; Roberts JM; Addiss DG; Radday J; Beach MJ; Streit TG; Dardith D; Lafontant JG; Lammie PJ
    Am J Trop Med Hyg; 2004 Oct; 71(4):466-70. PubMed ID: 15516644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination.
    Ghosh RS; Haldar P; Jacobson J
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):48-55. PubMed ID: 35292576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
    Krentel A; Basker N; Beau de Rochars M; Bogus J; Dilliott D; Direny AN; Dubray C; Fischer PU; Ga AL; Goss CW; Hardy M; Howard C; Jambulingam P; King CL; Laman M; Lemoine JF; Mallya S; Robinson LJ; Samuela J; Schechtman KB; Steer AC; Supali T; Tavul L; Weil GJ
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009002. PubMed ID: 33657090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
    de Rochars MB; Kanjilal S; Direny AN; Radday J; Lafontant JG; Mathieu E; Rheingans RD; Haddix AC; Streit TG; Beach MJ; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 2005 Nov; 73(5):888-94. PubMed ID: 16282299
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
    Kumar A; Sachan P; Bajpei A; Singh T
    J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A statistical approach to monitor ongoing intervention for control of lymphatic filariasis.
    Lakshmi A
    J Commun Dis; 2000 Mar; 32(1):10-6. PubMed ID: 11129559
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mass drug administration to treat lymphatic filariasis.
    Ravindran B
    Lancet; 2002 Jun; 359(9321):1948. PubMed ID: 12057582
    [No Abstract]   [Full Text] [Related]  

  • 69. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
    Cantey PT; Rout J; Rao G; Williamson J; Fox LM
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e728. PubMed ID: 20628595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
    Ottesen EA; Horton J
    Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent advances in the chemotherapy of lymphatic filariasis.
    Navaratnam V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting of children in filariasis mass drug administration.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Satyanarayana K
    Lancet; 2002 Nov; 360(9343):1430. PubMed ID: 12424026
    [No Abstract]   [Full Text] [Related]  

  • 74. Residual microfilaraemia in rural pockets of South India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign.
    Kalimuthu M; Sunish IP; Nagaraj J; Munirathinam A; Kumar VA; Arunachalam N; White GB; Tyagi BK
    J Vector Borne Dis; 2015 Jun; 52(2):182-4. PubMed ID: 26119554
    [No Abstract]   [Full Text] [Related]  

  • 75. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
    Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
    J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Control of lymphatic filariasis in a hunter-gatherer group in Madang Province.
    Bockarie MJ; Jenkins C; Blakie WM; Lagog M; Alpers MP
    P N G Med J; 2000; 43(3-4):196-202. PubMed ID: 11939301
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
    El-Setouhy M; Abd Elaziz KM; Helmy H; Farid HA; Kamal HA; Ramzy RM; Shannon WD; Weil GJ
    Am J Trop Med Hyg; 2007 Dec; 77(6):1069-73. PubMed ID: 18165524
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
    Biritwum NK; de Souza DK; Marfo B; Odoom S; Alomatu B; Asiedu O; Yeboah A; Hervie TE; Mensah EO; Yikpotey P; Koroma JB; Molyneux D; Bockarie MJ; Gyapong JO
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005280. PubMed ID: 28333930
    [No Abstract]   [Full Text] [Related]  

  • 79. Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
    Lemoine JF; Desormeaux AM; Monestime F; Fayette CR; Desir L; Direny AN; Carciunoiu S; Miller L; Knipes A; Lammie P; Smith P; Stockton M; Trofimovich L; Bhandari K; Reithinger R; Crowley K; Ottesen E; Baker M
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0004954. PubMed ID: 27706162
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road.
    Malecela MN; Mwingira U; Mwakitalu ME; Kabali C; Michael E; Mackenzie CD
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S53-7. PubMed ID: 19843398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.